News

ISA Pharmaceuticals participates in newly-launched Tumor Neoantigen Selection Alliance (TESLA)

ISA Pharmaceuticals participates in the newly-launched Tumor neoantigEn SeLection Alliance (TESLA), run by the Parker Institute for Cancer Immunotherapy and the Cancer Research Institute (CRI). Read the full press release here: